What Is Your Book Actually Worth? A Practical Guide to Advisor Practice Valuation

The short answer: Advisory practices are valued on adjusted EBITDA, and the market's median multiple has run close to 10x in recent transaction data, with wide dispersion around it: organic growth, recurring fee-based revenue, younger clients, and team depth earn premiums. Smaller books still trade on recurring-revenue multiples, but treating the old two-times-revenue rule of thumb as a valuation is how sellers leave money on the table.

Advisors quote rules of thumb. Buyers run models. The gap between those two habits is where practices get mispriced, deals get lost, and successions quietly fail.

Ask an advisor what their practice is worth and you will usually hear a revenue multiple, two times recurring is the old campfire number, passed down from an era when practices traded between individuals over handshakes. Ask the institutional buyers who now dominate the market and you will hear something else entirely: adjusted EBITDA, normalized margins, growth-adjusted multiples, structure.

This guide is about closing that gap, because in today's market the difference is not academic. It is frequently the difference between two prices for the same firm.

How does the market actually price an advisory practice?

Start with the number serious buyers start with: adjusted EBITDA, the practice's true earnings once owner compensation is normalized to market and one-time items are stripped out. The adjustment step matters more than the multiple. A $2 million revenue practice where the founder takes home $1.4 million is not a $1.4 million earnings business; market-rate compensation for the founder's advisory role has to come out first. Practices with real margins after that exercise are rarer than the industry's self-image suggests, which is exactly why they price well.

Then the multiple. In the most recent Advisor Growth Strategies deal data, drawn from actual transactions, the median adjusted EBITDA multiple ran just under 10x, easing marginally for the first time in the study's six-year history. Around that median sits enormous dispersion: scaled, growing, institutionalized firms transact meaningfully above it, and founder-dependent, slow-growth practices transact meaningfully below. The dispersion is the market telling you the multiple is an output. The inputs are the fundamentals.

Deal volume, meanwhile, remains historically strong even in a higher-rate world: 126 transactions in the first half of this year per DeVoe & Company, up 5 percent, on what the analysts call a steady plateau, with more than 80 distinct buyers active and mid-size sellers taking a growing share. Notably, firms between $200 million and $500 million have become the market's most competitive battleground; multiples in that segment rose roughly 40 percent over the seven years through 2022. You no longer need to be a billion-dollar enterprise to attract institutional bidding. You need to be good.

The valuation framework at a glance

A worked example

Take a $2 million revenue practice, 90 percent fee-based, with one founder and two staff.

1. Start with revenue: $2,000,000.
2. Normalize owner compensation. The founder takes home $1.2 million, but the market rate for the advisory work the founder performs is roughly $500,000. Earnings must be stated after paying someone to do the founder's job.
3. Compute adjusted EBITDA. After market-rate owner comp, staff, and operating expenses, the practice earns $550,000. That number, not revenue, is what a buyer is purchasing.
4. Apply the market multiple. At the recent median of just under 10x, the enterprise is worth roughly $5.4 million. Strong organic growth and younger clients could push the multiple higher; founder-dependence and an aging book would pull it lower.
5. Read the structure, not just the headline. A typical offer might arrive as roughly half cash at close, with the balance in earn-outs tied to retention and equity in the acquirer. The same $5.4 million headline is worth meaningfully different amounts depending on that mix.

Note what happened between steps 1 and 3: the "two times revenue" folklore would have quoted $4 million, and depending on the practice's real margins, that folk number can be materially high or materially low. This is why buyers run models and why sellers should too. To model the other side of the ledger, what a transition itself pays across W-2, IBD, and RIA paths, use our transition calculator.

What moves a practice valuation up or down?

Across the deal data and our own advisory work, the premium drivers are consistent enough to be a checklist:

• Organic growth. Real client and asset acquisition, separated from market appreciation. Nothing else on this list compensates for its absence.
• Recurring, fee-based revenue. The higher the share, the more your revenue looks like the annuity buyers are paying for.
• Client demographics. A book of accumulating fifty-somethings and multi-generational relationships outprices a book in systematic decumulation, at identical AUM.
• Team beyond the founder. If the relationships leave when you do, the buyer is purchasing your retirement risk. Depth, and demonstrated succession structure, converts personal goodwill into enterprise value.
• Margins that survive normalization. See above; this is where most self-estimates die.

Structure, finally, is half the price. Today's deals typically pair meaningful cash at close with risk-sharing components, earn-outs tied to retention or growth, rolled equity in the acquirer, seller financing, and in a higher-rate environment buyers have leaned harder on the contingent pieces. A headline number is not a price; a structure is. Two "10x" offers can differ by a third in risk-adjusted value.

Why does an internal successor pay less than an outside buyer?

Now the uncomfortable part of the current market, and the reason valuation belongs in every succession conversation years early.

The same practice increasingly carries two different prices: what an external, institutionally capitalized buyer will pay, and what an internal successor can finance. As valuations rose over the past decade, that spread widened from a nuance into a structural problem. David DeVoe put it diplomatically this summer: the difference between internal and large external offers "can be quite wide." Founders feel it as a dilemma; their G2 feels it as a locked door.

The gap is bridgeable, with earlier partial equity sales, seller notes, longer earn-ins, and deliberate structure, but every bridge takes years to build. Founders who discover the spread at the moment of exit are usually choosing between disappointing their successor and discounting their life's work. Founders who price the practice early get to design around it.

Know your number

Here is the practical close, and it applies to every advisor, including those with no intention of selling anything to anyone.

Your practice's enterprise value is the reference price for your entire professional life. Recruiting packages are bids against it. Retention deals are bids against it. Sunset programs, merger approaches, and the equity conversation with your junior partner are all bids against it. The consolidators and recruiters on the other side of those tables run the models constantly; the advisor who has never run one is negotiating blind against counterparties who know the number better than the owner does.

Getting the analysis done is neither expensive nor binding. It is a few weeks of work that converts every future conversation about your practice from feelings to figures. In a market with 80-plus active buyers and a decade of demographic demand behind it, the question is not whether your practice will be priced. It is whether you will be the first to know the price.

Winthrop & Co. provides confidential practice valuations and enterprise-value modeling for advisors and teams, and benchmarks every offer, recruiting, retention, or acquisition, against it. Start the conversation here.